The Ritedose Corporation

What does the future of drug manufacturing look like? What can a CDMO do to  manage the quickly changing landscape of pharmaceuticals? In this Endpoints News webinar, Alessandro Maselli, CEO of Catalent Pharma Solutions, talks with editor John Carroll about: -- Stability, trust and growth management that come from working with CDMOs -- What’s changing in the CDMO industry (consolidation, innovations, NDAs) -- The effect of “reshoring” from Asia to the US and/or Europe, thanks to the BIOSECURE Act and other factors At Ritedose, we can help you manage growth and deal with the changing CDMO climate! Watch the webinar recording: https://lnkd.in/e7z6BP6u

Looking to scale up your therapeutic manufacturing capacity? Will only the best in sterile processing be enough? At Ritedose, we take aseptic, efficient and excellent CDMO processes to heart, from clinical trial transition to BFS to fill and finish. Visit our website at ritedose.com and find out what we can do for you today!

Did you know about BFS? BFS—blow-fill-seal technology—is taking the pharmaceutical world by storm. Already, its market value is in excess of $3.2 billion, that market is expected to grow by 6.8 percent (CAGR) through 2033, where it’s estimated to total $6.2 billion.  Blow-fill-seal is The Ritedose Corporation’s key technology for drug manufacturing. It alleviates concerns about human error and interventions, and operates in a nearly 100 percent sterile process and environment. Plus, it’s simple and efficient. In fact, we recently announced we are expanding our BFS capabilities by 180-million-units for ophthalmic and respiratory medications. So, how does BFS work? BFS is used to make pre-measured, single-dose pharmaceutical products. With no human contact, a container is formed (blow), filled with product and then sealed, ready for delivery to patients. Blow—the container is formed by forcing the container material (which could be polymer plastic resins, or, less commonly, glass) into a mold, creating the container’s shape.  Fill—then, the container is filled with the drug product. Each dose is pre-measured according to the container size. Seal—the processor then closes off the top of the container, creating a secure seal and ensuring a sterile product. This tab that creates the seal can be easily twisted off when ready to dispense. Simple enough! Contact Ritedose to find out more about our BFS processes: https://ritedose.com/.

We're #hiring a new System Engineer (MES) in Columbia, South Carolina. Apply today or share this post with your network.

We're #hiring a new Sr. Manufacturing Operations Manager in Columbia, South Carolina. Apply today or share this post with your network.

At Ritedose, we love our community and are continually finding ways to support those around us because we know they are supportive of us! No one in this life is ever doing it all alone. On Wednesday, we were proud to support Harvest Hope Food Bank, South Carolina’s largest food bank. We encourage anyone looking to support an incredible organization to visit one of their locations and join us in making a difference! #CommunitySupport #GivingBack

We had a great time at our company Field Day together raising money for the American Heart Association last month to support initiatives such as Hands Only CPR training, improved healthcare quality in the Midlands, provision of blood pressure cuffs and refrigeration to organizations in need, and funding research and technology that will save countless lives: https://lnkd.in/gHmSj_8i

Did you know? Outsourced pharmaceutical manufacturing is about to become half of the total drug-making market this year. CDMOs, CROs and CMOs make up the bulk of this manufacturing market. Do you know the difference between them? CRO—contract research organizations provide early-stage research and development services, from pre-clinical basic science discoveries to clinical trials. Many of them focus on clinical trial research, regulatory affairs, planning, data management logics and biostatistics that are beyond the means of most academic laboratories and can partner with larger pharmaceutical firms. CMO—contract manufacturing organizations are focused on helping pharmaceutical and biotechnology companies manufacture new therapeutics and vaccines. This can involve commercial production, development, stability testing and optimizing, formulations, and manufacturing methods. CDMO—contract development and manufacturing organizations, like Ritedose, provide comprehensive, fully integrated research, development and manufacturing support. This includes regulatory expertise, clinical trials, formulation development, packaging, fill-and-finish, supply chain, quality control, and technology transfer. These three main organizations can work in synchrony, as well. CROS and work with CDMOs, for example, to maintain a seamless pathway between research and final manufacturing steps. CMOs can also help fill capacity needs for CDMOs. Find out more about the CDMO services Ritedose provides to its existing and  potential customers!

Happy 4th of July! We could do the routine post about celebrating this holiday and put out a generic post, but we figured we’d do something to highlight a famous American chemist born today! ER Squibb was born on July 4th, 1819. A pioneering pharmacist, he founded the pharmaceutical company E.R. Squibb & Sons in 1858. His innovations and ethical standards significantly impacted the pharmaceutical industry, emphasizing rigorous quality control and the importance of ethical practices in medicine.

ICYMI: Exciting Expansion at Ritedose! We’re thrilled to announce an expansion of our sterile BFS capabilities, adding a 180-million-unit dose capacity for ophthalmic and respiratory medications. Starting this August at our state-of-the-art Columbia, SC facility, this brings our total BFS capacity to over 2.6 billion units, making us the largest BFS manufacturer in the US. Learn more: bit.ly/3VQsa3M #PharmaIndustry #PharmaManufacturing #DrugDelivery #InvestmentInSC